​2. Mechanism of action (doctor‑friendly)

Deflazacort is a glucocorticoid prodrug that is converted to an active metabolite which binds to glucocorticoid receptors. This modulates gene expression, decreases pro‑inflammatory cytokines, and suppresses immune responses, thereby reducing inflammation and autoimmune activity.​

You can keep the explanation short on the site and add more detail in PDFs if needed.

3. Indications (how to list on site)

Use a clean bullet list such as:

TRUDEF 6 mg is used in the management of:​

• Musculoskeletal and joint inflammatory conditions: rheumatoid arthritis, ankylosing spondylitis, and other inflammatory arthritides.​

• Respiratory and allergic conditions: asthma exacerbations, severe allergic reactions, and other responsive allergic disorders.​

• Gastrointestinal and autoimmune conditions: inflammatory bowel disease, ulcerative colitis, Crohn’s disease, and other autoimmune disorders as per physician’s discretion.​

• Other steroid‑responsive conditions as guided by the treating specialist (e.g., certain dermatological, renal, and hematological disorders).

​Disclaimer line:

“Use is strictly as per physician’s judgment and relevant clinical guidelines.”

4. Key benefits (doctor messaging)

• Potent anti‑inflammatory action: Helps quickly control pain, swelling, and stiffness in inflammatory and autoimmune disorders.​

• Immunosuppressive effect: Modulates exaggerated immune responses in autoimmune diseases, limiting further tissue damage.​

• Flexible dosing: Can be titrated and tapered according to disease severity and treatment duration under medical supervision.​

Keep it crisp and clinical, focused on benefits to patient outcomes.

5. Safety / side‑effect section (patient‑friendly)

You can present this under a heading like “Safety and tolerability” with clear language:

Commonly reported side effects include:​

• Increased appetite and weight gain.​

• Frequent urination and fluid retention.​

• Cushingoid features with prolonged use (round face, central weight gain).​

• Increased risk of infections, cough, and upper respiratory tract infections.​

• Mood or sleep changes such as irritability or insomnia may also occur.​

Safety notes:

• Long‑term use may lead to bone thinning (osteoporosis), increased blood sugar, or blood pressure and must be monitored by a doctor.​

• TRUDEF 6 should not be stopped abruptly; tapering is required as per physician advice.​